Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Prostate cancer update: 2006.

Lin AM, Small EJ.

Curr Opin Oncol. 2007 May;19(3):229-33. Review.

PMID:
17414641
2.

Prostate cancer update: 2007.

Lin AM, Small EJ.

Curr Opin Oncol. 2008 May;20(3):294-9. doi: 10.1097/CCO.0b013e3282f8b075. Review.

PMID:
18391629
3.

Advances in prostate cancer.

Ryan CJ, Small EJ.

Curr Opin Oncol. 2004 May;16(3):242-6. Review.

PMID:
15069320
4.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
5.

Prostate cancer update: 2005.

Ryan CJ, Small EJ.

Curr Opin Oncol. 2006 May;18(3):284-8. Review.

PMID:
16552242
6.

Current controversies in the treatment of high-risk prostate cancer.

Mitchell RE, Chang SS.

Curr Opin Urol. 2008 May;18(3):263-8. doi: 10.1097/MOU.0b013e3282f9b37f. Review.

PMID:
18382235
7.

The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.

Reed AB, Parekh DJ.

Curr Opin Urol. 2009 May;19(3):238-42. doi: 10.1097/MOU.0b013e328329eb29. Review.

PMID:
19318950
8.

[Locally advanced prostate cancer: definition, prognosis and treatment].

Plantade A, Massard C, de Crevoisier R, Fizazi K.

Bull Cancer. 2007 Jul;94(7 Suppl):F50-61. Review. French.

PMID:
17845994
9.

Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review.

Pasquier D, Ballereau C.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):972-9. doi: 10.1016/j.ijrobp.2008.07.026. Review.

PMID:
18954710
10.

[Oncoforum in urology and review of the literature].

Hennequin C.

Cancer Radiother. 2008 Sep;12 Spec No 2:1-8. doi: 10.1016/S1278-3218(08)73947-7. Review. French.

PMID:
18823869
11.

Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.

Jereczek-Fossa BA, Orecchia R.

Radiother Oncol. 2007 Aug;84(2):197-215. Review.

PMID:
17532494
12.

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN.

Crit Rev Oncol Hematol. 2010 Jan;73(1):68-91. doi: 10.1016/j.critrevonc.2009.09.005. Review.

PMID:
19836968
13.

Prostate specific antigen recurrence after definitive therapy.

Freedland SJ, Moul JW.

J Urol. 2007 Jun;177(6):1985-91. Review.

PMID:
17509277
14.

Prostate cancer: screening, diagnosis, and management.

Garnick MB.

Ann Intern Med. 1993 May 15;118(10):804-18. Review. Erratum in: Ann Intern Med 1994 Apr 15;120(8):698.

PMID:
7682387
15.

The management of early prostate cancer: a review.

Ngugi PM, Magoha GA.

East Afr Med J. 2007 Sep;84(9 Suppl):S24-30. Review.

PMID:
18154199
16.
17.

Progress in detection and treatment of prostate cancer.

Ryan CJ, Small EJ.

Curr Opin Oncol. 2005 May;17(3):257-60. Review.

PMID:
15818171
18.

Screening for prostate cancer: opportunities for prevention.

Thompson IM, Coltman CA.

Semin Urol Oncol. 1996 May;14(2 Suppl 2):4-10; discussion 10-1. Review.

PMID:
8725886
19.

Advances in prostate cancer.

Small EJ.

Curr Opin Oncol. 1999 May;11(3):226-35. Review.

PMID:
10328599
20.

Management of locally advanced prostate cancer: past, present, future.

Swanson GP.

J Urol. 2006 Dec;176(6 Pt 2):S34-41. Review.

PMID:
17084164

Supplemental Content

Support Center